Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α-Reference-Cited by-同舟云学术

Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α

Published:2021-11 Issue:11 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Chen Yan¹²³,Zhang Jingyu¹²³,Zhang Minqin¹²³,Song Yuxuan¹²³,Zhang Yue²⁴,Fan Shuangqin¹²⁴,Ren Shuang¹²³,Fu Lingyun¹²³,Zhang Nenling¹⁴,Hui Hui⁵,Shen Xiangchun¹²³⁴^ORCID

Affiliation:

1. The State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Medical University Guizhou China

2. The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province School of Pharmaceutical Sciences Guizhou Medical University Guizhou China

3. The Union Key Laboratory of Guiyang City‐Guizhou Medical University School of Pharmaceutical Sciences Guizhou Medical University Guizhou China

4. The Key Laboratory of Optimal Utilization of Natural Medicine Resources School of Pharmaceutical Sciences Guizhou Medical University Guizhou China

5. State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Carcinogenesis and Intervention China Pharmaceutical University Nanjing China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guizhou Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.577

Reference61 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment

3. Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer

4. Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors

5. Metabolic reprograming confers tamoxifen resistance in breast cancer

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecules targeting mitochondria as an innovative approach to cancer therapy;Cellular Signalling;2024-12

2. CD44/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds;International Immunopharmacology;2024-09

3. The most recent progress of baicalein in its anti-neoplastic effects and mechanisms;Biomedicine & Pharmacotherapy;2024-07

4. Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3β/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1α;Journal of Experimental & Clinical Cancer Research;2024-06-27

5. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies;Signal Transduction and Targeted Therapy;2024-05-27